Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Amneal Pharmaceuticals ( (AMRX) ) has provided an announcement.
On January 23, 2026, Amneal Pharmaceuticals said it would implement a nationwide opioids settlement after securing sufficient participation from all eligible state and territorial attorneys general and all subdivisions that had sued the company, with the agreement becoming effective on January 29, 2026. Under the settlement, Amneal will pay participating states and local governments $88.5 million and provide up to $177.4 million worth of naloxone nasal spray to treat opioid overdoses, with an option for settling parties to receive 25% of the naloxone’s value in cash during the final four years of the ten-year payment term, potentially raising the total cash outlay to as much as $132.9 million and helping the company resolve a substantial majority of its opioid-related liabilities.
The most recent analyst rating on (AMRX) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Amneal Pharmaceuticals stock, see the AMRX Stock Forecast page.
Spark’s Take on AMRX Stock
According to Spark, TipRanks’ AI Analyst, AMRX is a Neutral.
Amneal Pharmaceuticals’ stock score is primarily influenced by its strong technical indicators, suggesting positive momentum. However, the high P/E ratio raises concerns about overvaluation. Financial performance shows steady growth but challenges in profitability and cash flow growth. The earnings call and corporate events highlight strong operational performance and strategic initiatives, but these factors are not weighted in the final score.
To see Spark’s full report on AMRX stock, click here.
More about Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. is a U.S.-based pharmaceutical company operating in the generic and specialty drug industry, with a portfolio that includes treatments for various medical conditions and a notable presence in products related to pain management and addiction treatment.
Average Trading Volume: 1,789,198
Technical Sentiment Signal: Buy
Current Market Cap: $4.27B
For a thorough assessment of AMRX stock, go to TipRanks’ Stock Analysis page.